Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Infections 1Graft vs Host Disease 1Congenital Abnormalities 1

Interventions

Cytarabine 28Etoposide 12Daunorubicin 11fludarabine phosphate 10Busulfan 10Peripheral Blood Stem Cell Transplantation 9tipifarnib 8Vorinostat 7Mitoxantrone 7Cyclosporine 7laromustine 6alvocidib 6Filgrastim 6Decitabine 6Cyclophosphamide 6Antilymphocyte Serum 6Idarubicin 5Methotrexate 4Bortezomib 4valspodar 3sargramostim 3romidepsin 3Radiotherapy 3Polymerase Chain Reaction 3Mycophenolic Acid 3Methylprednisolone 3Melphalan 3Gene Expression Profiling 3tanespimycin 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Congenital Abnormalities × Bronchoalveolar Lavage × Clear all
NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

National Cancer Institute (NCI)

Phase NA Unknown
200 enrolled
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡